
MindMaze Shareholders Reject Capital Increase Proposal
MindMaze Therapeutics shareholders rejected a proposed increase in conditional share capital during the company's annual general meeting in Geneva on June 25, 2026. While the board secured a qualified majority on most agenda items, this specific financial expansion failed to gain the necessary support from investors.






.jpg?disable=upscale&width=1200&height=630&fit=crop)


















